The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 29, 2018

Filed:

Oct. 15, 2014
Applicants:

Massachusetts Institute of Technology, Cambridge, MA (US);

Yale University, New Haven, CT (US);

Inventors:

Bogdan I. Fedeles, Cambridge, MA (US);

Sorin V. Fedeles, Hamden, CT (US);

Robert G. Croy, Belmont, MA (US);

Stefan Somlo, Westport, CT (US);

John M. Essigmann, Cambridge, MA (US);

Assignees:

Massachusetts Institute of Technology, Cambridge, MA (US);

Yale University, New Haven, CT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/56 (2006.01); C07J 41/00 (2006.01); A61K 31/122 (2006.01); A61K 31/567 (2006.01);
U.S. Cl.
CPC ...
C07J 41/0077 (2013.01); A61K 31/122 (2013.01); A61K 31/567 (2013.01);
Abstract

The present invention provides compounds of Formula (I) or (II), which are thought to be able to inhibit mTOR (mammalian target of rapamycin) signaling pathway, induce UPR (unfolded protein response), and/or perturb mitochondrial function of a cyst cell (e.g., a cyst cell causing polycystic kidney disease (PKD, e.g., autosomal dominant PKD (ADPKD) or autosomal recessive PKD (ARPKD)) or polycystic liver disease (PLD, e.g., autosomal dominant PLD (ADPLD) or autosomal recessive PLD (ARPLD)). The invention also provides pharmaceutical compositions, kits, and methods involving the compounds described herein for use in treating PKD or PLD, inhibiting the growth of a cyst cell, and/or killing a cyst cell.


Find Patent Forward Citations

Loading…